Pluripotent characterization verifies self-renewal and differentiation capacity. Our services deliver validated stem cell lines via integrated molecular signatures, imaging, and functional assays using advanced MEA electrophysiology and qPCR scorecarding. Creative Biolabs offers comprehensive analytical solutions, resolving phenotypic drift, ensuring compliance with global standards for therapy and drug screening.
Discover How We Can Help - Request a Consultation
This suite integrates a full spectrum of assays to rigorously validate the identity, pluripotency, and genomic stability of pluripotent stem cell lines. It combines morphological observation of compact, undifferentiated colonies, molecular detection of core pluripotency markers via qPCR and protein assays, functional validation through embryoid body and teratoma formation, and genomic integrity checks using karyotype analysis. These complementary methods collectively ensure that stem cell lines meet the stringent standards required for research and clinical applications.
Fig.1 Characterization of hiPSC and QC methods.1
| Assay Category | Services | Core Purpose |
|---|---|---|
| Morphology | Morphology Observation Service | Evaluate colony morphology (compact, dome-shaped) to identify undifferentiated pluripotent stem cells. |
| Functional Pluripotency Assay | Teratoma Formation Assay Service | Verify trilineage differentiation potential in vivo by inducing tumor formation containing ectoderm, mesoderm, and endoderm tissues. |
| Functional Pluripotency Assay | Embryoid Body Formation & Characterization Service | Assess in vitro trilineage differentiation ability by generating and analyzing EB-derived cell lineages. |
| Genomic Stability Assay | Karyotype Analysis Service | Detect chromosomal abnormalities (deletions, translocations) to ensure genomic integrity. |
| Genetic Identification Assay | Gender Determination Service | Confirm the sex chromosome composition of stem cell lines for experimental consistency. |
| Functional Characterization | High-Resolution Electrophysiological Characterization Service | Evaluate electrophysiological properties of differentiated derivatives (e.g., neurons, cardiomyocytes). |
| Molecular Pluripotency Assay | Pluripotency Marker Analysis Service via qPCR | Quantify the expression level of core pluripotency genes (Oct4, Sox2, Nanog) via real-time PCR. |
| Molecular Pluripotency Assay | Pluripotency Marker Analysis Service via Immunofluorescence (IF) Assay | Detect the presence of pluripotency-related proteins (SSEA-4, TRA-1-60) using methods like immunofluorescence or flow cytometry. |
Our workflow is engineered for maximum transparency and scientific rigor, providing a clear roadmap from sample receipt to the final validation report.
At Creative Biolabs, we recognize that every regenerative medicine project carries unique biological complexities. We don't just provide data; we provide a customized partnership designed to elevate your cell line's profile. Our Pluripotency Characterization & Quality Control Services offers:
Tailored selection of markers and assays to meet your specific research goals or regulatory requirements.
From initial colony morphology and qPCR scorecarding to advanced MEA electrophysiology and in vivo teratoma assays.
Implementation of Quality-by-Design (QbD) principles and process analytical techniques (PAT) to ensure reproducibility across batches.
Rigorous testing to verify the stability of iPSC/ESC lines throughout cell banking and large-scale expansion protocols.
Procedures and results are assessed by our qualified quality assurance team, providing audit-ready reports for your peace of mind.
Direct access to our senior biology specialists to interpret complex bioinformatics and "molecular signature" data.
Services that grow with you, from initial laboratory-scale characterization to large-scale clinical-grade validation.
Experience the Creative Biolabs Advantage - Get a Quote Today
A: While AP staining is a helpful, quick indicator of undifferentiated states, it is far from a definitive measure of true pluripotency. Our services provide a comprehensive "Molecular Signature" that moves beyond superficial enzymatic activity. By combining quantitative qPCR scorecarding with high-resolution flow cytometry and functional differentiation assays, we identify truly pluripotent clones that AP staining alone might misclassify, thereby preventing the use of subpar cell lines in critical downstream applications.
A: Yes. We have extensive experience characterizing lines generated via Sendai virus, episomal plasmids, and mRNA-based reprogramming techniques. Importantly, our characterization protocols include specialized, highly sensitive assays to ensure the complete clearance of these reprogramming factors. This verification is crucial for therapeutic applications where the presence of residual exogenous genetic material or viral remnants could pose significant safety risks or interfere with cellular behavior.
A: To ensure statistical significance and robust data, we generally require approximately 60-80% confluence in a standard 10 cm culture dish. However, we understand that sample availability can be a constraint in early-stage research. For specific targeted assays, such as transcriptomic qPCR or population-based Flow Cytometry, we can often work with significantly smaller cell pellets.
A: Yes, our reporting is specifically designed to facilitate your regulatory journey. We strictly adhere to the international guidelines established by the ISCBI and ISSCR. Our comprehensive reports provide the high-standard documentation, validated methodologies, and rigorous data interpretation required by global regulatory agencies. This ensures that your characterization package is "audit-ready," significantly streamlining the filing process for Investigational New Drug (IND) applications.
A: Integrity and transparency are central to our service. If a sample exhibits atypical morphology or early signs of spontaneous differentiation upon arrival, we do not simply proceed blindly. Instead, we provide an immediate preliminary report and initiate a technical consultation. We work closely with you to decide whether to pause the project to optimize your upstream culture conditions or to proceed with specific molecular tests that might identify the underlying cause of the phenotypic drift, ensuring your resources are never wasted on non-viable lines.
Creative Biolabs provides an end-to-end solution for Pluripotency Characterization & Quality Control Services, from basic morphological screening to advanced functional electrophysiology. Our goal is to ensure your cell lines are safe, stable, and ready for the next phase of your project.
Contact Our Team for More Information and to Discuss Your Project
Reference
For Research Use Only. Not For Clinical Use.
